NPF's Parkinson's Outcomes Project
The National Parkinson Foundation recently released early findings from the largest clinical study of Parkinson’s ever conducted, showing that depression is the most important factor influencing the quality of life and health of Parkinson’s patients. The study, known as the Quality Improvement Initiative (QII) is collecting data from more than 5,000 people with Parkinson’s in four countries. QII is one part of the NPF’s broader Parkinson’s Outcomes Project to determine what works best in treatment and care with an aim toward slowing the impact of the disease.
AbbVie Announces U.S. FDA Approval of DUOPA for Parkinson's Treatment
January 12, 2015
"There is unmet need for treatment options for patients with advanced Parkinson's disease. As the disease advances, it can be difficult to control motor features," said C. Warren Olanow, M.D., Professor, Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine, and lead investigator of the DUOPA pivotal trial. "In clinical trials, DUOPA was shown to significantly reduce the amount of off time advanced Parkinson's disease patients experienced." Read more.
More Evidence Linking Gut Bacteria to Parkinson’s Disease: A Guide for Patients
January 5, 2015
Considerable evidence has been mounting supporting a relationship between the gastrointestinal system and Parkinson’s disease. Many pathologists and neurologists believe that Parkinson’s disease may start in the gut, however this view remains speculative. Additionally, there are many GI symptoms such as constipation that occur as prominent and disabling features of Parkinson’s disease. Read more.
Home for the Holidays: Spotting the First Signs of Parkinson's Disease
December 18, 2014
The holidays are often a time of year when families are reunited after having spent months, even years, apart. While many will spend their time reminiscing over a home-cooked meal and warm holiday cookies, some may face a realization that the health of a loved one is diminishing. Seeing changes in those we love can be unsettling – even scary. And, in some cases, what you see and what you identify can be vital in getting proper treatment for a serious condition. Read more.
Atlanta Man Finds Help for Parkinson's Disease in Boxing Gym
December 10, 2014
Larry Kahn has fallen in love with boxing. He says, “ I feel empowered, I just feel stronger." His wife of 29 years, Ellie says, “He's a fighter. I love it. On a good day, he's giving it all he's got and he's doing combat." And on bad days, when the fatigue sets it, Ellie says, "It's hard. But you're there. Because that's what you're there for. We're in this together." Read more.
Families Struggle with Young Onset Diseases
December 6, 2014
On Roger Roessler’s first date with Rosie, his phone rang and when he picked it up, his hand shook. “You should probably watch that,” said Rosie, jokingly, at the time. “It could be Parkinson’s.” Five years later, after marriage, three kids and an accident that severed three of Roger’s fingers, it turns out he does have Parkinson’s Disease. Read more.
Exercise's Benefits Proven for Parkinson's Disease Patients
November 11, 2014
Studies have shown that exercise can help slow the progression of Parkinson’s disease, but the actual exercise habits of patients and the real results of it had not been explored until a recent Northwestern Medicine study. Analyzing data from nearly 5,000 patients with Parkinson’s disease, the investigators found that regular exercise is associated with better quality of life and slower rates of decline. Read more.
US Senator Cory Booker PSA for National Parkinson Foundation
November 5, 2014
released a public service announcement (PSA) featuring U.S. Senator Cory Booker (NJ) to raise awareness of the early warning signs of the disease and the important role family and friends play in caring for those affected. Read more.
CNN Vital Signs with Dr. Sanjay Gupta looks at Deep Brain Stimulation at UF Health
November 5, 2014
The National Parkinson Foundation is proud to share the following video from CNN's show, Vital Signs with Dr. Sanjay Gupta. The video features our National Medical Director, Dr. Michael S. Okun, and Dr. Kelley Foote, both of the University of Florida Health Center for Movement Disorders and Neurorestoration. Read more.
Emory University to Join the National Parkinson Foundation Center of Excellence Network
October 31, 2014
The Jean and Paul Amos Parkinson’s Disease and Movement Disorders Program at Emory University has been designated a Center of Excellence by the National Parkinson Foundation (NPF). This competitive designation is the highest recognition offered by NPF to a Parkinson’s specialty clinic and represents the consensus of peers and leaders in the field that the Emory Center is among the world’s leading centers for Parkinson’s research, outreach and care. Read more.
The National Parkinson Foundation Partners with the International Parkinson and Movement Disorder Society to Deliver Health Professional Course
October 14, 2014
The National Parkinson Foundation (NPF) and the International Parkinson and Movement Disorder Society (MDS) Pan American Section (MDS-PAS) announced today a collaborative partnership to offer a three-day course to teach team care and increase knowledge of Parkinson's disease (PD). The course, Allied Team Training for Parkinson's Disease (ATTP) will take place in San Diego, CA, from November 13-15, 2014. Read more.
Dealing With Parkinson’s Disease-Related Depression
October 14, 2014
Depression in Parkinson’s disease patients is a little like the riddle about the chicken and the egg: Which came first – the nervous system disorder characterized by impaired movement and slurred speech, or the depression that is both an early symptom of the disease as well as a consequence of it? Read more.
Breakthrough Replicates Human Brain Cells for Use in Alzheimer’s Research
October 12, 2014
For the first time, and to the astonishment of many of their colleagues, researchers created what they call 'Alzheimer’s in a Dish' — a petri dish with human brain cells that develop the telltale structures of Alzheimer’s disease. In doing so, they resolved a longstanding problem of how to study Alzheimer’s and search for drugs to treat it; the best they had until now were mice that developed an imperfect form of the disease. Read more.